Topics

Jakafi Significantly Improves Long-Term Outcomes in Myelofibrosis

03:26 EDT 29 Apr 2019 | Cancer Connect

Single agent Jakafi improves treatment of Myelofibrosis - researchers report on novel Jakafi combinations with Hydrea...

Original Article: Jakafi Significantly Improves Long-Term Outcomes in Myelofibrosis

NEXT ARTICLE

More From BioPortfolio on "Jakafi Significantly Improves Long-Term Outcomes in Myelofibrosis"

Quick Search